Omega-3 boost in pregnancy may lower stress and help Baby's brain
NCT ID NCT02647723
First seen Jun 02, 2026 · Last updated Jun 23, 2026 · Updated 2 times
Summary
This study looks at whether taking DHA (an omega-3 fatty acid) supplements during pregnancy can improve maternal health and infant development. Researchers are giving 168 low-income African American women either DHA or a placebo daily for 24 weeks. They will measure stress levels and track baby outcomes after birth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILD DEVELOPMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Chicago Medicine
Chicago, Illinois, 60637, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DHA (docosahexaenoic acid, an omega-3 fatty acid) as a dietary supplement
What this could lead to
If successful, this could show that taking DHA during pregnancy helps reduce stress and supports healthier development in babies.
What could go wrong
This is an early-stage study with only 168 participants, so results may not apply to all women. The supplement may not show significant benefits over placebo.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.